QUEBEC CITY, March 21 /CNW Telbec/ - AEterna Zentaris Inc. (TSX: AEZ;
Nasdaq: AEZS) announced that it will host a live webcast of the presentations
from its Analyst and Investor Day being held today beginning at 9:30 a.m.
(ET). AEterna Zentaris' management will present the Company's strategy as a
late-stage, pure play biopharmaceutical company, an update on the development
of its lead compounds cetrorelix, ozarelix and perifosine, as well as other
earlier-stage, promising product candidates.
The live webcast of these presentations will be available on the
Company's website at www.aeternazentaris.com in the Investors section. A
replay will also be available for a period of 30 days.
About AEterna Zentaris Inc.
AEterna Zentaris Inc. is a late-stage, global biopharmaceutical company
focused on endocrine therapy and oncology with proven expertise in drug
discovery, development and commercialization.
News releases and additional information are available at
For further information:
For further information: Jenene Thomas, Senior Director, Investor
Relations & Corporate Communications, (418) 655-6420,
email@example.com; Paul Burroughs, Media Relations, (418)
652-8525 ext. 406, firstname.lastname@example.org